NAFLD can occur after liver transplantation (LT), as recurrence or de novo hepatic steatosis
(HS). We aimed to evaluate the literature on prevalence, risk factors, and prognosis of post …

Background Liver stiffness measurement (LSM) and controlled attenuation parameter (CAP)
are used for diagnosis of liver fibrosis and steatosis. This study aimed to noninvasively …

AIM To investigate incidence and predictors of NAFLD and NASH by employing noninvasive
testing in liver transplant recipients, namely controlled attenuation parameter (CAP) and the …

Highlights•NASH is now the second most common indication for liver transplant.•Metabolic
syndrome incidence is rising post-transplant with improved survival.•Tailoring …

To the Editor, Liver transplantation (LT) is the only curative therapy for patients with end‐
stage liver disease. 1 Due to the high incidence of metabolic syndrome after LT …

Materials and Methods A cross-sectional prospective study was conducted involving 128
adult patients who had undergone LT, and had received liver imaging, and vibration …

Chronic liver injury and subsequent liver fibrosis are usually a slow process without any
specific or no clinical signs, resulting in pathological conditions with a poor chance of …

BACKGROUND: Liver transplant (LT) recipients, patients with type 2 diabetes (T2D), and
people with HIV represent at-risk populations for nonalcoholic fatty liver disease (NAFLD) …